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Introduction: The discovery that many tissues express the vitamin D receptor and are able 
to transform the 25-hydroxyvitamin D into 1,25-dihydroxyvitamin D (active metabolite) has 
led to the hypothesis that vitamin D could have a role in the pathogenesis and prevention of 
diabetes mellitus. Accumulating evidence has linked vitamin D deficiency with   immunological 
disturbance in type 1 diabetes mellitus. Several epidemiological studies have shown lower 
serum 25-hydroxyvitamin D concentrations in diabetic individuals compared to nondiabetic 
individuals.
Patients and methods: A total of 105 Lebanese patients with type 1 diabetes mellitus were 
recruited. Levels of HbA1c and vitamin D were recorded during two phases with phase 1 being 
the period from June–September 2009 and phase 2 from January–April 2009.
Results: Vitamin D levels at the end of sunny season (phase 2), reflecting the previous sunny 
months, were found to be higher than in the early summer season (phase 1) reflecting the previ-
ous cloudy months season, with a mean change of 0.70 ± 6.87 ng/mL (P = 0.029). HbA1c levels 
were higher in phase 2 than in phase 1 with an increase of 0.175% ± 1.46% (P = 0.113).
Conclusion: Vitamin D levels were higher at the end of the sunny season than at the end of 
cloudy season. HbA1c was also lower (but not significantly so) in the early summer season 
(cloudy months). There was a weak correlation between seasonal changes of vitamin D levels 
and the control of blood glucose as monitored by HbA1c in a cohort of Lebanese patients with 
type 1 diabetes mellitus.
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Introduction
Type 1 diabetes mellitus (T1DM) is a T-cell mediated autoimmune disease that results 
in the destruction of insulin producing beta cells in the pancreas requiring exog-
enous insulin for survival.1 The beta-cell destruction often begins during infancy and 
  continues over many months or years. By the time T1DM is diagnosed, about 80% 
of the beta-cells have been destroyed.2 Although it is acknowledged to be an autoim-
mune disease, the causes are still considered to be unknown.3 Epidemiologic studies 
of T1DM have directed the search for possible genetic predispositions and related 
  environmental factors that are still poorly defined.4 Some identified environmental risk 
factors operating early in life include enteroviral infections in pregnant women, older 
maternal age (39–42 years), preeclampsia, cesarean section delivery, increased birth 
weight, early introduction of cow’s milk proteins, and an increased rate of postnatal 
growth (weight and height).5,6 There is a need to find the cause of this chronic disease 
because there has been an increase its incidence over time. It is estimated that currently International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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the incidence is increasing by 3% per year and this cannot 
be explained by genetic factors only.2 Several approaches 
have been tried to prevent T1DM but none of them have 
been shown to work, and the prevention of T1DM remains 
an objective for the future.7
Recent evidence has reported that vitamin D deficiency 
predisposes individuals to T1DM and T2DM. Several studies 
show that vitamin D has several effects on the immune system 
and insulin synthesis and secretion, therefore suggesting a role 
in the development of both types of diabetes. Studies have 
shown that diabetic individuals are more vitamin D   deficient 
than nondiabetic individuals.8 Vitamin D deficiency is 
  becoming a global public health problem although it is largely 
unrecognized.9–12 It has been estimated that 1 billion people 
worldwide have vitamin D deficiency or insufficiency.13
The aim of our study is to show that better glycemic control 
achieved in patients with T1DM during the sunny season com-
pared to the cloudy season is related to change in the levels of 
serum 25-hydroxyvitamin D.4–6 Our second aim is to determine 
whether lower values of glycosylated hemoglobin (HbA1c) noted 
during the end of the cloudy season compared to the end of the 
sunny season is associated with higher levels of vitamin D.
Patients and methods
The study recruitment was done at the Chronic Care Center 
in Hazmieh, Lebanon. The center is a specialized institu-
tion for the treatment and follow-up of childhood chronic 
T1DM. A total of 105 Lebanese patients with T1DM were 
recruited. Patient characteristics are presented in Table 1. 
Level of 25-hydroxyvitamin D was assessed in the patients 
at two different phases: phase 1 from June–September 2009, 
reflecting the previous cloudy 6 months, and phase 2 from 
January–April 2009, reflecting the previous sunny 6 months. 
For each phase, the level of HbA1c was also recorded for each 
patient. Serum 25-hydroxyvitamin D levels for both phases 
were measured by using the radioimmunoassay immunodi-
agnostics system kit and HbA1c was determined by the high 
performance liquid chromatography method using a Variant 
kit (Bio-Rad Laboratories, Philadelphia, PA).
The study protocol has been reviewed and approved by 
the Ethics Committee at the Chronic Care Center as well as 
the Institutional Review Board at the American University 
of Beirut. A signed informed consent was obtained from all 
patients.
Results
When analyzing for a trend of vitamin D and HbA1c change, 
vitamin D levels in phase 2 were found to be more elevated 
than in phase 1 with a mean change of 0.70 ± 6.87 ng/mL 
(P = 0.029). Similarly, HbA1c levels were higher in phase 2 
than in phase 1 with an increase of 0.175% ± 1.46%. However 
this trend regarding blood sugar control was not significant 
(P = 0.113).
Both HbA1c and serum vitamin D levels were found to be 
higher during the early cloudy season (end of sunny season; 
phase 2) as opposed to early summer season (phase 1). When 
analyzing for a correlation, it was found to be very weak 
with the Spearman coefficient being −0.046 (P = 0.661). 
Thus it seems that both HbA1c and vitamin D levels tend to 
increase over the early cloudy season (end of sunny season) 
and decrease in the early summer season (Figure 1). It is 
important to note that this tendency did not reach significance 
for the HbA1c fluctuation.
Discussion
The existence of vitamin D receptors in activated T   lymphocytes, 
antigen-presenting cells (macrophages and dendritic cells), 
and thymus tissue raised the idea that 1,25-dihydroxyvitamin D 
(1,25(OH)2D) might function as an immunomodulator.14–16 
The fact that immune cells (activated macrophages and 
dendritic cells in particular) also contain the enzyme 1-alpha-
hydroxylase, which is necessary for the final activating step in 
the conversion of 25-hydroxyvitamin D to the metabolically 
Table 1 Participant characteristics
Mean age (years) 18.75 ± 6.35
Mean duration of diabetes mellitus (years) 7.9 ± 6.0
Sex distribution (%) 56.7% male, 43.3% female
Mean body mass index at baseline (kg/m2) 23.2 ± 4.2
Mean waist circumference (cm) 82.2 ± 12.1
Mean hip circumference (cm) 96.8 ± 11.2
Baseline fasting blood sugar (mg/dL) 152.9 ± 91.4
0
5
10
15
20
25
30
Mean vitamin D (ng/mL)
Phase 1 = early summer season
Phase 2 = end of sunny season 
HbA1c (%)
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active molecule, shows that these cells are able to synthesize 
and secrete 1,25(OH)2D which is able to target the immune 
system.8
In order to provide evidence that vitamin D affects the 
risk of developing T1DM, several studies have been done 
using animal models such as nonobese diabetic (NOD) mice. 
A study conducted by Mathieu et al reported that 1,25(OH)2D 
has been shown to reduce T1DM onset in NOD mice. He 
administrated 5 µg/kg of 1,25(OH)2D in the NOD mice and 
found that diabetes incidence in NOD mice at 200 days was 
reduced to 8% in the 1,25(OH)2D-treated group vs 56% in 
the control group.17 A study conducted by Zella et al reported 
that a vitamin D deficient state alone can potentiate diabetic 
onset in the NOD mouse. The authors also found that daily 
dietary supplementation with 2000 IU of 1,25(OH)2D pre-
vents diabetes over 200 days regardless of vitamin D status 
before the study.18 They suggested that oral administration 
of 1,25(OH)2D or preferably a nonhypercalcemic analog 
would be clinically relevant for the prevention of T1DM in 
humans.16
In our study we aimed to show that an increase in vitamin 
D serum level is correlated to an improvement in glycemic 
control as shown in a decrease in HbA1c levels. Interestingly 
the vitamin D level was significantly higher at the end of the 
sunny season than in the summer season itself. The vitamin 
D levels reported by this study were taken in Lebanon at 
latitude 33°N and were lower than the ones reported by 
Greer in Australia (latitude 29°S) and by Littorin in Sweden 
(latitude 55–65°N).19,20 It seems that vitamin D levels in our 
study are affected by factors relevant to developing coun-
tries21 rather than purely on geographical/solar distribution 
considerations.22 In a national US study, it was found that the 
average American spent 93% of their 24-hour day indoors. 
Air conditioning, computers, video games, and extensive 
television programming are reasons behind the increas-
ing time spent indoors with decrease in outdoor activities. 
Because of the current changes in lifestyles, humans are now 
more dependent on foods rich in vitamin D or oral vitamin 
D supplementation and less exposed to sunlight even in 
  summer.23 Remarkably in the sunniest areas of the world, vita-
min D deficiency is also a major health problem. It was found 
that in Saudi Arabia, India, Turkey, New Zealand, Egypt, Hong 
Kong, China, Libya, Lebanon, Spain, Australia, San Diego, 
California, and the southeastern US 35%–80% of children 
are vitamin D deficient. We cannot always assume that just 
because there is more abundant sunlight outdoors vitamin 
D levels would be higher in summer season compared to 
winter.10 Nevertheless it is important to note that the study’s 
focus is not on the vitamin D absolute level but rather on its 
trend with seasonal change. Diabetes control as represented 
by HbA1c seems to be affected by seasonality with a mean 
rise of 0.175% ± 1.46%. These results did not reach statistical 
significance in our study but showed a trend for better control 
of glycemia during the end of the cloudy months.
In this study, however, no correlation could be found 
between diabetes control and variation of vitamin D level in 
a population of Lebanese with T1DM. Moreover, vitamin D 
levels tend to significantly increase at the end of the summer 
season and this is associated with better blood sugar control.
Future studies are needed with a larger sample size and a 
standardized questionnaire for the level of exercise, accuracy 
of insulin dosing, and timing of insulin injection. Such studies 
will provide more data on any possible relationship between 
vitamin D and diabetes pathogenesis and control.
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